MoneyWorks4Me

Indrayani Biotech - Quaterly Results

14 Nov 2022 Evaluate
The company witnessed a 11.26% growth in the revenue at Rs. 159.22 millions for the quarter ended September 2022 as compared to Rs. 143.10 millions during the year-ago period.The Company has registered profit of Rs. 12.96  millions for the quarter ended September 2022, a growth of 17.71%  over Rs. 11.01 millions millions achieved in the corresponding quarter of last year.Operating profit for the quarter ended September 2022 rose to 22.71 millions as compared to 17.15 millions of corresponding quarter ended September 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 159.22 143.10 11.26 315.20 285.54 10.39 579.89 210.07 176.05
Other Income 0.62 0.37 67.57 4.44 0.62 616.13 2.21 2.64 -16.29
PBIDT 22.71 17.15 32.42 40.20 29.15 37.91 64.49 -44.13 -246.14
Interest 5.67 5.29 7.18 9.57 8.51 12.46 18.80 19.61 -4.13
PBDT 14.54 11.86 22.60 28.13 20.64 36.29 45.69 -104.84 -143.58
Depreciation 1.58 0.85 85.88 2.75 1.69 62.72 3.44 4.03 -14.64
PBT 12.96 11.01 17.71 25.38 18.95 33.93 42.25 -108.87 -138.81
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 12.96 11.01 17.71 25.38 18.95 33.93 42.25 -108.87 -138.81
Equity 342.27 342.27 0.00 342.27 342.27 0.00 342.27 342.27 0.00
PBIDTM(%) 14.26 11.98 19.01 12.75 10.21 24.93 11.12 -21.01 -152.94
Peers
Company Name CMP
Grasim Industries 3188.00
DCM Shriram 984.20
3M India 34722.30
Hindustan Foods 617.45
Balmer Lawrie & Co 166.15
View more..